7Baggers
 immunitybio reports revenue surge amid financial challenges  TipRanks Wed, 12 Nov 2025 04:04:48 GMT
 immunitybio inc. (ibrx) stock price | live quotes & charts | nasdaq  StocksToTrade Sat, 08 Nov 2025 00:40:00 GMT
 ImmunityBio’s Shareholder Reforms Agreement Gets Court Sendoff  Bloomberg Law News Thu, 06 Nov 2025 17:39:00 GMT
 immunitybio: q3 earnings snapshot  CT Insider Thu, 06 Nov 2025 09:39:09 GMT
 immunitybio (ibrx) projected to post earnings on tuesday  MarketBeat Wed, 05 Nov 2025 15:19:54 GMT
 immunitybio reports q3 eps (7c), consensus (11c)  TipRanks Wed, 05 Nov 2025 11:41:20 GMT
 ImmunityBio, Inc. SEC 10-Q Report  TradingView Wed, 05 Nov 2025 11:13:00 GMT
 ImmunityBio: Q3 Earnings Snapshot  San Francisco Chronicle Wed, 05 Nov 2025 08:00:00 GMT
 immunitybio inc earnings beat by $0.04, revenue topped estimates  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 immunitybio q3 revenue jumps on anktiva demand  MarketScreener Wed, 05 Nov 2025 08:00:00 GMT
 immunitybio shares face unrelenting downward spiral  AD HOC NEWS Tue, 04 Nov 2025 16:34:04 GMT
 immunitybio, inc. (ibrx) analyst insights, price targets and recommendations  Yahoo! Finance UK Fri, 31 Oct 2025 19:42:39 GMT

ImmunityBio, Inc
(NASDAQ:IBRX) 

IBRX stock logo

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to combat multiple tumor types without the use of high-dose chemotherapy. It develops an albumin-linked chemotherapeutic therapy (Aldoxorubicin), a novel IL-15 cytokine superagonist (N-803), checkpoint inhibitors, m...

Founded: 2014
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends